Seong L. Khaw

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2026

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

Journal: Research square

Published: August 20, 2026

Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.

Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 29, 2026

Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study.

Venetoclax in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors: Results of a Phase 1 Study.

Journal: Pediatric blood & cancer

Published: April 11, 2025

Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia.

Venetoclax Alone or in Combination With Chemotherapy in Paediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Myeloid Leukaemia.

Journal: Pediatric blood & cancer

Published: November 14, 2024

Chimeric antigen receptor T cell therapy in childhood leukaemia.

Chimeric antigen receptor T cell therapy in childhood leukaemia.

Journal: Archives of disease in childhood

Published: November 11, 2024

Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia.

Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: September 12, 2023

A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax.

A novel MYB::PAIP1 oncogenic fusion in pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) is dependent on BCL2 expression and is sensitive to venetoclax.

Journal: HemaSphere

Published: August 31, 2023

Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia.

Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia.

Journal: EJHaem

Published: August 08, 2023

Late effects in survivors of infant acute lymphoblastic leukaemia-a study of the Australian and New Zealand Children's Haematology/Oncology Group.

Late effects in survivors of infant acute lymphoblastic leukaemia-a study of the Australian and New Zealand Children's Haematology/Oncology Group.

Journal: Blood cancer journal

Published: July 25, 2023

Severe persistent neurotoxicity associated with CAR T therapy in children.

Severe persistent neurotoxicity associated with CAR T therapy in children.

Journal: British journal of haematology

Published: May 08, 2023

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 18, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026